DK1478362T3 - Kombinationsbehandling til akut myokardisk infarkt - Google Patents
Kombinationsbehandling til akut myokardisk infarktInfo
- Publication number
- DK1478362T3 DK1478362T3 DK03700828T DK03700828T DK1478362T3 DK 1478362 T3 DK1478362 T3 DK 1478362T3 DK 03700828 T DK03700828 T DK 03700828T DK 03700828 T DK03700828 T DK 03700828T DK 1478362 T3 DK1478362 T3 DK 1478362T3
- Authority
- DK
- Denmark
- Prior art keywords
- myocardial infarction
- acute myocardial
- combination therapy
- combination
- levosimendan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020197A FI20020197A0 (fi) | 2002-02-01 | 2002-02-01 | Yhdistelmä akuutin myokardiilisen infarktin hoitoon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1478362T3 true DK1478362T3 (da) | 2005-11-14 |
Family
ID=8563019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03700828T DK1478362T3 (da) | 2002-02-01 | 2003-01-31 | Kombinationsbehandling til akut myokardisk infarkt |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20050255096A1 (es) |
| EP (1) | EP1478362B1 (es) |
| JP (1) | JP2005516050A (es) |
| CN (1) | CN1291718C (es) |
| AT (1) | ATE306267T1 (es) |
| AU (1) | AU2003201980B2 (es) |
| BR (1) | BR0307317A (es) |
| CA (1) | CA2474430C (es) |
| DE (1) | DE60301862T2 (es) |
| DK (1) | DK1478362T3 (es) |
| ES (1) | ES2249707T3 (es) |
| FI (1) | FI20020197A0 (es) |
| HK (1) | HK1077215A1 (es) |
| IL (1) | IL163091A (es) |
| MX (1) | MXPA04007345A (es) |
| NZ (1) | NZ534221A (es) |
| PL (1) | PL212241B1 (es) |
| WO (1) | WO2003063870A1 (es) |
| ZA (1) | ZA200406085B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR298901A0 (en) | 2001-02-07 | 2001-03-08 | McComb Foundation, Inc., The | Cell suspension preparation technique and device |
| FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
| US20070010518A1 (en) * | 2005-02-18 | 2007-01-11 | Matti Kivikko | Method for administering levosimendan |
| US9375440B2 (en) * | 2006-11-03 | 2016-06-28 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| US8324367B2 (en) | 2006-11-03 | 2012-12-04 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| WO2008082871A1 (en) * | 2006-12-28 | 2008-07-10 | Orion Corporation | Formulations of levosimendan for parenteral administration |
| AU2013205148B2 (en) | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
| AU2020408323A1 (en) | 2019-12-16 | 2022-08-11 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF) |
| CN115518037A (zh) * | 2022-10-14 | 2022-12-27 | 上药东英（江苏）药业有限公司 | 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972990A (en) * | 1992-04-10 | 1999-10-26 | Brigham And Women's Hospital, Inc. | Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims |
| GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
| US5626601A (en) * | 1995-10-27 | 1997-05-06 | Gary Gershony | Vascular sealing apparatus and method |
| US5510330A (en) * | 1994-03-25 | 1996-04-23 | Boehringer Mannheim Gmbh | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| US5463564A (en) * | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
-
2002
- 2002-02-01 FI FI20020197A patent/FI20020197A0/fi unknown
-
2003
- 2003-01-31 DE DE60301862T patent/DE60301862T2/de not_active Expired - Lifetime
- 2003-01-31 MX MXPA04007345A patent/MXPA04007345A/es active IP Right Grant
- 2003-01-31 US US10/502,981 patent/US20050255096A1/en not_active Abandoned
- 2003-01-31 JP JP2003563560A patent/JP2005516050A/ja active Pending
- 2003-01-31 NZ NZ534221A patent/NZ534221A/xx not_active IP Right Cessation
- 2003-01-31 AU AU2003201980A patent/AU2003201980B2/en not_active Ceased
- 2003-01-31 EP EP03700828A patent/EP1478362B1/en not_active Expired - Lifetime
- 2003-01-31 PL PL371741A patent/PL212241B1/pl not_active IP Right Cessation
- 2003-01-31 BR BR0307317-3A patent/BR0307317A/pt not_active Application Discontinuation
- 2003-01-31 DK DK03700828T patent/DK1478362T3/da active
- 2003-01-31 WO PCT/FI2003/000078 patent/WO2003063870A1/en active IP Right Grant
- 2003-01-31 CA CA2474430A patent/CA2474430C/en not_active Expired - Fee Related
- 2003-01-31 AT AT03700828T patent/ATE306267T1/de active
- 2003-01-31 CN CNB038030918A patent/CN1291718C/zh not_active Expired - Fee Related
- 2003-01-31 ES ES03700828T patent/ES2249707T3/es not_active Expired - Lifetime
-
2004
- 2004-07-19 IL IL163091A patent/IL163091A/en not_active IP Right Cessation
- 2004-07-29 ZA ZA200406085A patent/ZA200406085B/en unknown
-
2005
- 2005-10-20 HK HK05109333A patent/HK1077215A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003063870A1 (en) | 2003-08-07 |
| NZ534221A (en) | 2007-06-29 |
| MXPA04007345A (es) | 2004-11-26 |
| CN1291718C (zh) | 2006-12-27 |
| PL371741A1 (en) | 2005-06-27 |
| IL163091A (en) | 2012-06-28 |
| CN1625398A (zh) | 2005-06-08 |
| FI20020197A0 (fi) | 2002-02-01 |
| CA2474430C (en) | 2010-09-28 |
| ES2249707T3 (es) | 2006-04-01 |
| BR0307317A (pt) | 2005-01-04 |
| PL212241B1 (pl) | 2012-08-31 |
| CA2474430A1 (en) | 2003-08-07 |
| ATE306267T1 (de) | 2005-10-15 |
| HK1077215A1 (en) | 2006-02-10 |
| EP1478362B1 (en) | 2005-10-12 |
| JP2005516050A (ja) | 2005-06-02 |
| DE60301862T2 (de) | 2006-07-20 |
| US20050255096A1 (en) | 2005-11-17 |
| AU2003201980B2 (en) | 2006-12-07 |
| EP1478362A1 (en) | 2004-11-24 |
| DE60301862D1 (de) | 2006-02-23 |
| ZA200406085B (en) | 2005-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1077215A1 (en) | A pharmaceutical composition for treatment of acute myocardial infarction | |
| DK1173178T3 (da) | Præparat, der omfatter apomorfin og sildenafil, og anvendelse deraf til behandling af erektil dysfunktion | |
| NO20032027D0 (no) | Effektive antitumorbehandlinger | |
| TW200616608A (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
| AR037524A1 (es) | Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion | |
| AU2002332488A8 (en) | R-bambuterol, its preparation and therapeutic uses | |
| PT1408977E (pt) | Terapia de combinacao para o tratamento de falha cardiaca | |
| GB0020504D0 (en) | Therapeutic method | |
| TW200509909A (en) | Use of organic compounds | |
| DE60111622D1 (de) | Getrennte dosis therapien mit gefässschädigender aktivität | |
| DK1303307T3 (da) | Kombinationsterapi mod tumorer omfattende substituerede acryloyldistamycinderivater og alkyleringsmidler | |
| ATE371446T1 (de) | Zusammensetzungen zur verhinderung der adhäsion | |
| DE60235965D1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz | |
| TW200509922A (en) | Methods of therapeutic treatment using amounts of retinoid components | |
| CO5170404A1 (es) | Terapia para melanomas | |
| NO20043774L (no) | The use of devazenide as analgesic agent |